Search results for "Norpregnadienes"

showing 2 items of 2 documents

3H-estradiol and3H-R5020 binding in cytosols of normal and neoplastic human ovarian tissue

1983

High-affinity cytoplasmic estrogen and progesterone receptors in normal and abnormal ovarian tissues were studied. Estradiol receptor was detectable in 65% and progesterone receptor in 36% of the malignant tumors; 39% of all malignant ovarian tissues were estradiol- as well as progesterone-receptor-positive. Tumors were said to be receptor-positive when the receptors bound greater than 5 fM steroid/mg cytosol protein. No correlations were found between receptor status and histopathological diagnosis. In normal ovarian tissues collected at various phases of the menstrual cycle no changes in [3H]-estradiol and [3H]-R5020 binding could be detected. Analysis of the receptor concentration for bo…

Cancer Researchmedicine.medical_specialtyReceptor StatusNorpregnadienesmedicine.drug_classmedia_common.quotation_subjectOvaryReceptors EstradiolBiologyTritiumPromegestoneCytosolOvarian carcinomaInternal medicineProgesterone receptormedicineHumansEstrogen Receptor StatusMenstrual cyclemedia_commonOvarian NeoplasmsTranscortinEstradiolOvaryEndocrinologymedicine.anatomical_structureReceptors EstrogenOncologyEstrogenFemaleReceptors Progesteronehormones hormone substitutes and hormone antagonistsTamoxifenmedicine.drugInternational Journal of Cancer
researchProduct

Hysteroscopic and ultrasonographic evaluation of ulipristal acetate treatment for symptomatic myomas in premenopausal women: a prospective study

2020

Objective: This study aimed to analyze the effects of a six-month therapy with ulipristal acetate (UPA) on myoma size and endometrial thickness in premenopausal women. Material and methods: Seventy-four women undergoing conservative therapy with UPA were enrolled for this study. All women underwent transvaginal ultrasound evaluation to assess the endometrial thickness, and the number and size of myomas at the beginning and after six months. Hysteroscopy and biopsy were performed after six months, if necessary. Results: After six months of treatment, sonographic examination showed a statistically significant (p <.05) reduction of the size of the largest myoma (56.3 ± 5.1 vs. 31.7 ± 10.1 m…

medicine.medical_specialtyNorpregnadienesUterine fibroidsHysteroscopy03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePregnancyUlipristal acetateSelective progesterone receptor modulatorulipristal acetatemedicineHumansProspective Studiesuterine fibroidsProspective cohort studyGynecologyLeiomyomamedicine.diagnostic_testbusiness.industryMetrorrhagiaMyomaselective progesterone receptor modulatormedicine.diseaseMyomachemistryHysteroscopy030220 oncology & carcinogenesisUterine NeoplasmsFemale030211 gastroenterology & hepatologySurgerymedicine.symptombusinessmetrorrhagia
researchProduct